In vitro evaluation of CENTA, a new beta-lactamase-susceptible chromogenic cephalosporin reagent

55Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

CENTA is a newly synthesized, beta-lactamase-labile, chromogenic cephalosporin reagent which changes color from light yellow (λ maximum ca. 340 nm) to chrome yellow (λ maximum ca. 405 nm) concomitant with hydrolysis of the beta-lactam ring. This compound offers promise as a diagnostic reagent comparable to other chromogens (PADAC and nitrocefin) for the early detection of beta-lactamase-producing clinical isolates, while retaining some antimicrobial effect against Escherichia coli, Klebsiella spp., Proteus mirabilis, Staphylococcus aureus, and non-enterococcal Streptococcus spp. CENTA is relatively unaffected by commonly used microbiological media and human serum.

Cite

CITATION STYLE

APA

Jones, R. N., Wilson, H. W., Novick, W. J., Barry, A. L., & Thornsberry, C. (1982). In vitro evaluation of CENTA, a new beta-lactamase-susceptible chromogenic cephalosporin reagent. Journal of Clinical Microbiology, 15(5), 954–958. https://doi.org/10.1128/jcm.15.5.954-958.1982

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free